Pharmaceutical Commerce

AUGUST 11, 2022

Pharmaceutical distribution today is anything but monolithic. While companies in this space are grappling with issues ranging from inflation and supply chain disruption to workforce scarcity and DSCSA implementation, there’s still plenty of room for smaller players to stake out part of the terrain to call their own.

Distribution 116

Distribution Pharmaceutical Distribution Pharma Pharmaceutical 116

Pharmacy Times

MAY 17, 2024

Natalie Bedford, senior vice president, US Pharmaceutical Distribution Services at McKesson, discusses the unique challenges of distributing specialty drugs.

Distribution 26

Distribution Pharmaceutical Distribution Pharmaceutical 26

Pharmaceutical Technology

MAY 30, 2023

The Italian pharmaceutical company Abiogen Pharma completed an acquisition of a 97.09% stake in the Swiss orphan conditions-focused EffRx Pharmaceuticals on May 29. Altamedics specialises in pharmaceutical distribution in hospital settings.

Pharmaceutical Distribution 52

Pharmaceutical Distribution Distribution Medicine Pharmaceutical 52

Celeritas

OCTOBER 14, 2022

Medical Science Liaisons are hired or contracted to meet with these stakeholders prior to and during the launch and distribution period to educate and create awareness of the drug. Begin the stakeholder mapping process by making a precise list of actors who will play a part in the pharmaceutical distribution process.

Pharmaceutical products 52

Pharmaceutical products Pharmaceutical Distribution Pharmaceutical Distribution 52

Pharmaceutical Technology

SEPTEMBER 14, 2022

The list includes companies that provide various products and services, including: Manufacturing of reagents for peptide synthesis Large-scale manufacturing of peptides Manufacturing of biologically active peptides and complex organic molecules Scale-up of complex peptides Development and production of therapeutic proteins, such as soluble proteins (..)

Leads 40

Leads Marketing Pharmacology Retail 40

Celeritas

OCTOBER 23, 2022

It’s important to first identify all actors who will play a part in the pharmaceutical distribution process. But what determines which members of the medical community will be valuable to approach for any given proposition? Who are Key Opinion Leaders (KOLs) in the Veterinarian field?

Medical science 40

Medical science Medical Specialization Doctors 40